Advert - Eli Lilly - CASE/0685/08/25

Eli Lilly – Case/0685/08/25

For its provision of a press release to the BBC, which promoted a prescription only medicine, orforglipron, prior to the grant of its marketing authorisation, Eli Lilly was ruled in breach of the following clauses of the 2024 Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.1 - Promoting a medicine prior to the grant of its marketing authorisation

Clause 5.1 - Failing to maintain high standards

The case report is available at www.pmcpa.org.uk.